MUC1介导急性髓系白血病患者髓源性抑制细胞的扩增
研究显示急性髓系白血病(AML)患者外周血髓源性抑制细胞(MDSC)较正常对照增多,MDSC可来源于白血病性或表观正常的前体细胞。AML来源的细胞外囊泡(EV)被髓系前体细胞摄取后选择性促进MDSC增殖,MUC1作为关键驱动因子通过c-myc及miR34a调控该过程。
要点
- AML患者外周血MDSC较正常对照增多,MDSC可源于白血病性或表观正常前体细胞。
- AML细胞与供者外周血单个核细胞共培养可细胞接触依赖性地扩增MDSC。
- MUC1经EV中的c-myc及miR34a驱动MDSC选择性增殖。
核心结论
- AML患者MDSC增多,可由白血病性或表观正常前体细胞来源,并抑制自体T细胞反应。
- AML来源EV被髓系前体细胞摄取后选择性促进MDSC增殖,MUC1为关键驱动因子。
- MUC1通过上调EV中c-myc并经miR34a调控,驱动靶MDSC群体增殖。
研究设计与样本
- 实验研究:比较AML患者与正常对照外周血MDSC;采用C57BL/6小鼠移植TIB-49 AML模型。
- 体外共培养AML细胞系MOLM-4、THP-1或原代AML细胞与供者外周血单个核细胞。
主要发现
- AML患者外周血MDSC较正常对照增多;C57BL/6小鼠移植TIB-49 AML后骨髓和脾脏CD11b+ Gr1+ MDSC扩增。
- 共培养引起细胞接触依赖的MDSC扩增;MDSC抑制自体T细胞反应,表现为T细胞增殖降低及Th1向Th2表型转换。
- 示踪研究显示AML EV被髓系前体细胞摄取,相较功能健全的抗原提呈细胞选择性促进MDSC增殖。
- MUC1诱导EV中c-myc表达升高,经下游细胞周期蛋白作用促进靶MDSC群体增殖;miR34a是MUC1驱动AML细胞及EV中c-myc表达的调控机制。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloid-derived suppressor cells (MDSCs) play a critical role in promoting immune tolerance and disease growth. The mechanism by which tumor cells evoke the expansion of MDSCs in acute myeloid leukemia (AML) has not been well described. We have demonstrated that patients with AML exhibit increased presence of MDSCs in their peripheral blood, in comparison with normal controls. Cytogenetic studies demonstrated that MDSCs in patients with AML may be derived from leukemic or apparently normal progenitors. Engraftment of C57BL/6 mice with TIB-49 AML led to an expansion of CD11b+ Gr1+ MDSCs in bone marrow and spleen. Coculture of the AML cell lines MOLM-4, THP-1 or primary AML cells with donor peripheral blood mononuclear cells elicited a cell contact-dependent expansion of MDSCs. MDSCs were suppressive of autologous T-cell responses as evidenced by reduced T-cell proliferation and a switch from a Th1 to a Th2 phenotype. We hypothesized that the expansion of MDSCs in AML is accomplished by tumor-derived extracellular vesicles (EVs). Using tracking studies, we demonstrated that AML EVs are taken-up myeloid progenitor cells, resulting in the selective proliferation of MDSCs in comparison with functionally competent antigen-presenting cells. The MUC1 oncoprotein was subsequently identified as the critical driver of EV-mediated MDSC expansion. MUC1 induces increased expression of c-myc in EVs that induces proliferation in the target MDSC population via downstream effects on cell cycle proteins. Moreover, we demonstrate that the microRNA miR34a acts as the regulatory mechanism by which MUC1 drives c-myc expression in AML cells and EVs.
引用
- Pyzer AR, Stroopinsky D, Rajabi H, et al. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia. Blood. 2017. PMID: 28126925. doi:10.1182/blood-2016-07-730614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。